Predictive And Pharmacodynamic Biomarker Profiling Optimized To Conserve Precious Clinical Trial Samples

In this webinar, Dr. Donald A. Skifter, SVP, Genomics at Discovery Life Sciences, will describe optimized approaches to performing genomic, proteomic, and cell-based biomarker analyses from low quantity, and in some cases low quality, clinical trial samples with a single chain-of-custody to make the most efficient use of these precious samples. These optimized protocols and processes facilitate more comprehensive biomarker profiling from each patient than was possible in the past, with the goal of enabling faster and more accurate targeting of therapies to the right populations.